TrialAmerican journal of clinical oncology2013

Phase II trial of pemetrexed plus gemcitabine in patients with locally advanced and metastatic nonclear cell renal cell carcinoma.

Stephen L Richey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.